Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.30 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13427041 | 0.94 | KDM4E (0.30) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL13427473 | 0.92 | KDM4E (0.33) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL13008466 | 0.91 | KDM4E (0.31) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL13008447 | 0.91 | HSD17B3 (0.37) | HSD17B3 | |
| SCHEMBL13008836 | 0.90 | — | — | |
| SCHEMBL13428162 | 0.90 | ALDH1A1 (0.33) | HSD17B3 | |
| SCHEMBL13427628 | 0.89 | MEN1 (0.33) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL13428217 | 0.89 | HSD17B3 (0.32) | HSD17B3 | |
| SCHEMBL13428181 | 0.88 | KDM4E (0.31) | KDM4EMEN1MAPTMAPK1KMT2A | |
| SCHEMBL13427310 | 0.88 | KDM4E (0.31) | KDM4EMEN1MAPTMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | KDM4E 4138/4885MEN1 3994/4885MAPT 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.